Floatz logo

Timolol

ALK-TKI

Queen Mary Hospital, Hong KongSmall moleculePhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the ALK-TKI cohort.

Asset / SponsorPhaseRating
BETAMETHASONE
Queen Mary Hospital, Hong Kong
Phase 3B

Same molecule, other indications

Timolol is also rated in:

paronychiaDormant
B
Indicative ·
57 / 100
View asset →
migraine disorderDormant
CCC
Indicative ·
52 / 100
View asset →
melanomaDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →